(Información remitida por la empresa firmante)
View original content:https://www.prnewswire.co.uk/news-releases/cantargia-advances-trifour-trial-to-randomized-stage-following-promising-early-safety-and-efficacy-of-nadunolimab-in-triple-negative-breast-cancer-301754102.html